These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30536102)

  • 1. Canine Liver Fibrosis Model to Assess the Functions of Infused Autologous Bone Marrow-Derived Cells.
    Takami T; Tani K; Taura Y; Sakaida I
    Methods Mol Biol; 2019; 1905():201-209. PubMed ID: 30536102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.
    Nishimura T; Takami T; Sasaki R; Aibe Y; Matsuda T; Fujisawa K; Matsumoto T; Yamamoto N; Tani K; Taura Y; Sakaida I
    PLoS One; 2019; 14(1):e0210588. PubMed ID: 30673721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
    Iwamoto T; Terai S; Hisanaga T; Takami T; Yamamoto N; Watanabe S; Sakaida I
    Cell Tissue Res; 2013 Mar; 351(3):487-95. PubMed ID: 23183782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
    Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
    Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced therapies using autologous bone marrow cells for chronic liver disease.
    Takami T; Terai S; Sakaida I
    Discov Med; 2012 Jul; 14(74):7-12. PubMed ID: 22846198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
    Sakaida I
    Rinsho Byori; 2011 Dec; 59(12):1092-8. PubMed ID: 22338911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients.
    Takami T; Terai S; Sakaida I
    J Pharmacol Sci; 2011; 115(3):274-8. PubMed ID: 21350310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow stem cell transplantation attenuates hepatocyte apoptosis in a rat model of ex vivo liver resection and liver autotransplantation.
    Xu T; Wang X; Chen G; He Y; Bie P
    J Surg Res; 2013 Oct; 184(2):1102-8. PubMed ID: 23830366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cell therapy using autologous bone marrow cells for liver cirrhosis.
    Sakaida I; Terai S; Nishina H; Okita K
    Med Mol Morphol; 2005 Dec; 38(4):197-202. PubMed ID: 16378227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis.
    Matsuura K; Takami T; Maeda M; Hisanaga T; Fujisawa K; Saeki I; Matsumoto T; Hidaka I; Yamamoto N; Sakaida I
    Transplant Proc; 2019 Apr; 51(3):925-935. PubMed ID: 30979485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis.
    Terai S; Sakaida I; Nishina H; Okita K
    J Hepatobiliary Pancreat Surg; 2005; 12(3):203-7. PubMed ID: 15995808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
    Kim JK; Kim SJ; Kim Y; Chung YE; Park YN; Kim HO; Kim JS; Park MS; Sakaida I; Kim DY; Lee JI; Ahn SH; Lee KS; Han KH
    Cell Transplant; 2017 Jun; 26(6):1059-1066. PubMed ID: 28120743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
    Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
    Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
    Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
    Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow cell infusion therapy for liver cirrhosis patients.
    Terai S; Sakaida I
    J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):23-5. PubMed ID: 20632039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
    Terai S; Takami T; Yamamoto N; Fujisawa K; Ishikawa T; Urata Y; Tanimoto H; Iwamoto T; Mizunaga Y; Matsuda T; Oono T; Marumoto M; Burganova G; Fernando Quintanilha L; Hidaka I; Marumoto Y; Saeki I; Uchida K; Yamasaki T; Tani K; Taura Y; Fujii Y; Nishina H; Okita K; Sakaida I
    Tissue Eng Part B Rev; 2014 Jun; 20(3):206-10. PubMed ID: 24450831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis.
    de Oliveira SA; de Freitas Souza BS; Sá Barreto EP; Kaneto CM; Neto HA; Azevedo CM; Guimarães ET; de Freitas LA; Ribeiro-Dos-Santos R; Soares MB
    Cytotherapy; 2012 Mar; 14(3):339-49. PubMed ID: 22149185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis.
    Quintanilha LF; Mannheimer EG; Carvalho AB; Paredes BD; Dias JV; Almeida AS; Gutfilen B; Barbosa da Fonseca LM; Resende CM; Rezende GF; Campos de Carvalho AC; Goldenberg RC
    Cell Transplant; 2008; 17(8):943-53. PubMed ID: 19069636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of liver fibrosis by intrasplenic injection of high-density cultured bone marrow cells in a rat chronic liver injury model.
    Lian J; Lu Y; Xu P; Ai A; Zhou G; Liu W; Cao Y; Zhang WJ
    PLoS One; 2014; 9(9):e103603. PubMed ID: 25255097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.